This discovery challenges conventional perspectives and introduces a novel interpretation: MLL1F-induced leukemias likely originate from a dominant-negative impact on MLL1’s histone methyltransferase activity, like the consequences observed here with a homozygous loss-of-function mutation in the MLL1 gene within iPS cells. Here, PRDM9 is linked to leukemia.